ArticleJournal of translational medicine2017

Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma.

Yali Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.